BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25993694)

  • 1. Neutrophil Extracellular Traps in Ulcerative Colitis: A Proteome Analysis of Intestinal Biopsies.
    Bennike TB; Carlsen TG; Ellingsen T; Bonderup OK; Glerup H; Bøgsted M; Christiansen G; Birkelund S; Stensballe A; Andersen V
    Inflamm Bowel Dis; 2015 Sep; 21(9):2052-67. PubMed ID: 25993694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil Extracellular Traps Sustain Inflammatory Signals in Ulcerative Colitis.
    Dinallo V; Marafini I; Di Fusco D; Laudisi F; Franzè E; Di Grazia A; Figliuzzi MM; Caprioli F; Stolfi C; Monteleone I; Monteleone G
    J Crohns Colitis; 2019 May; 13(6):772-784. PubMed ID: 30715224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
    Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
    Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil extracellular traps-associated protein peptidyl arginine deaminase 4 immunohistochemical expression in ulcerative colitis and its association with the prognostic predictors.
    Abd El Hafez A; Mohamed AS; Shehta A; Sheta HAEAS
    Pathol Res Pract; 2020 Oct; 216(10):153102. PubMed ID: 32853943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REDD1/Autophagy Pathway Is Associated with Neutrophil-Driven IL-1β Inflammatory Response in Active Ulcerative Colitis.
    Angelidou I; Chrysanthopoulou A; Mitsios A; Arelaki S; Arampatzioglou A; Kambas K; Ritis D; Tsironidou V; Moschos I; Dalla V; Stakos D; Kouklakis G; Mitroulis I; Ritis K; Skendros P
    J Immunol; 2018 Jun; 200(12):3950-3961. PubMed ID: 29712770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of calprotectin in colon mucosa and fecal of patients with ulcerative colitis].
    Liu WB; Lü YM; Jin Z; Yang XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):179-82. PubMed ID: 15841150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.
    Muthas D; Reznichenko A; Balendran CA; Böttcher G; Clausen IG; Kärrman Mårdh C; Ottosson T; Uddin M; MacDonald TT; Danese S; Berner Hansen M
    Scand J Gastroenterol; 2017 Feb; 52(2):125-135. PubMed ID: 27610713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis.
    Hanai H; Takeuchi K; Iida T; Kashiwagi N; Saniabadi AR; Matsushita I; Sato Y; Kasuga N; Nakamura T
    Dig Dis Sci; 2004 Sep; 49(9):1438-43. PubMed ID: 15481316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal transcriptomics implicates under expression of BRINP3 in the pathogenesis of ulcerative colitis.
    Smith PJ; Levine AP; Dunne J; Guilhamon P; Turmaine M; Sewell GW; OʼShea NR; Vega R; Paterson JC; Oukrif D; Beck S; Bloom SL; Novelli M; Rodriguez-Justo M; Smith AM; Segal AW
    Inflamm Bowel Dis; 2014 Oct; 20(10):1802-12. PubMed ID: 25171508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of inflamed and non-inflamed colon biopsies reveals strong proteomic inflammation profile in patients with ulcerative colitis.
    Poulsen NA; Andersen V; Møller JC; Møller HS; Jessen F; Purup S; Larsen LB
    BMC Gastroenterol; 2012 Jun; 12():76. PubMed ID: 22726388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis.
    Haga K; Chiba A; Shibuya T; Osada T; Ishikawa D; Kodani T; Nomura O; Watanabe S; Miyake S
    J Gastroenterol Hepatol; 2016 May; 31(5):965-72. PubMed ID: 26590105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis.
    Taghvaei T; Maleki I; Nagshvar F; Fakheri H; Hosseini V; Valizadeh SM; Neishaboori H
    Intern Emerg Med; 2015 Apr; 10(3):321-8. PubMed ID: 25366383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
    Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
    Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock transcription factor 2 predicts mucosal healing and promotes mucosal repair of ulcerative colitis.
    Wen Y; Niu J; Zhang F; Wu J; Li M; Sun Y; Wang W; Xia S; Tan Y; Wang K; Miao Y
    Scand J Gastroenterol; 2020 Jun; 55(6):677-686. PubMed ID: 32538201
    [No Abstract]   [Full Text] [Related]  

  • 17. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Specific Calprotectin Neo-epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity.
    Mortensen JH; Sinkeviciute D; Manon-Jensen T; Domislović V; McCall K; Thudium CS; Brinar M; Önnerfjord P; Goodyear CS; Krznarić Ž; Karsdal MA; Bay-Jensen AC
    J Crohns Colitis; 2022 Sep; 16(9):1447-1460. PubMed ID: 35304895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls.
    Lundgren D; Rutegård J; Eklöf V; Palmqvist R; Karling P
    BMC Gastroenterol; 2016 Nov; 16(1):139. PubMed ID: 27881072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis.
    Scaioli E; Sartini A; Bellanova M; Campieri M; Festi D; Bazzoli F; Belluzzi A
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1268-1275.e2. PubMed ID: 29391271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.